Philip Toleikis, Sernova CEO
June 26, 2023 03:23 PM EDTUpdated 04:59 PM
R&D

Ser­no­va says five di­a­betes pa­tients have now been tak­en off in­sulin af­ter 'cell pouch' ther­a­py

Lei Lei Wu

News Reporter

Five pa­tients with type 1 di­a­betes have stopped tak­ing in­sulin af­ter get­ting Ser­no­va’s cell trans­plant treat­ment, the Cana­di­an biotech re­port­ed Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times